Palliative procedures for malignant gastric outlet obstruction: a network meta-analysis

Abstract

Background The optimal treatment for malignant gastric outlet obstruction (GOO) remains uncertain. This systematic review aimed to comprehensively investigate the efficacy and safety of four palliative treatments for malignant GOO: gastrojejunostomy, endoscopic ultrasound-guided gastroenterostomy (EUS-GE), stomach-partitioning gastrojejunostomy (PGJ), and endoscopic stenting.

Methods We searched PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform for randomized controlled trials (RCTs) and cohort studies comparing the four treatments for malignant GOO. We included studies that reported at least one of the following clinical outcomes: clinical success, 30-day mortality, reintervention rate, or length of hospital stay. Evidence from RCTs and non-RCTs was naïve combined to perform network meta-analysis through the frequentist approach using an inverse variance model. Treatments were ranked by P score.

Results This network meta-analysis included 3617 patients from 4 RCTs, 4 prospective cohort studies, and 32 retrospective cohort studies. PGJ was the optimal approach in terms of clinical success and reintervention (P scores: 0.95 and 0.90, respectively). EUS-GE had the highest probability of being the optimal treatment in terms of 30-day mortality and complications (P scores: 0.82 and 0.99, respectively). Cluster ranking to combine the P scores for 30-day mortality and reintervention indicated the benefits of PGJ and EUS-GE (cophenetic correlation coefficient: 0.94; PGJ and EUS-GE were in the same cluster).

Conclusion PGJ and EUS-GE are recommended for malignant GOO. PGJ could be the alternative choice in centers with limited resources or in patients who are unsuitable for EUS-GE.

Publication History

Received: 04 December 2023

Accepted after revision: 19 April 2024

Accepted Manuscript online:
19 April 2024

Article published online:
31 May 2024

• References

• 1 Bronswijk M, Vanella G, van Malenstein H. et al. Laparoscopic versus EUS-guided gastroenterostomy for gastric outlet obstruction: an international multicenter propensity score-matched comparison (with video). Gastrointest Endosc 2021; 94: 526-536.e522
• 2 Jang S, Stevens T, Lopez R. et al. Superiority of gastrojejunostomy over endoscopic stenting for palliation of malignant gastric outlet obstruction. Clin Gastroenterol Hepatol 2019; 17: 1295-1302.e1291
• 3 Del Piano M, Ballarè M, Montino F. et al. Endoscopy or surgery for malignant GI outlet obstruction?. Gastrointest Endosc 2005; 61: 421-426 DOI: 10.1016/s0016-5107(04)02757-9. (PMID: 15758914)
• 4 Fiori E, Lamazza A, Demasi E. et al. Endoscopic stenting for gastric outlet obstruction in patients with unresectable antro pyloric cancer. Systematic review of the literature and final results of a prospective study. The point of view of a surgical group. Am J Surg 2013; 206: 210-217
• 5 Jeurnink SM, Steyerberg EW, van Hooft JE. et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71: 490-499 DOI: 10.1016/j.gie.2009.09.042. (PMID: 20003966)
• 6 Singh A, Ross WA, Bhattacharya A. et al. Gastrojejunostomy versus enteral self-expanding metal stent placement in patients with a malignant gastric outlet obstruction. Gastrointestinal Intervention 2013; 2: 94-98
• 7 Kumagai K, Rouvelas I, Ernberg A. et al. A systematic review and meta-analysis comparing partial stomach partitioning gastrojejunostomy versus conventional gastrojejunostomy for malignant gastroduodenal obstruction. Langenbecks Arch Surg 2016; 401: 777-785 DOI: 10.1007/s00423-016-1470-8. (PMID: 27339200)
• 8 Upchurch E, Ragusa M, Cirocchi R. Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. Cochrane Database Syst Rev 2018; 5: CD012506 DOI: 10.1002/14651858.CD012506.pub2. (PMID: 29845610)
• 9 Chandan S, Khan SR, Mohan BP. et al. EUS-guided gastroenterostomy versus enteral stenting for gastric outlet obstruction: systematic review and meta-analysis. Endosc Int Open 2021; 9: E496-E504 DOI: 10.1055/a-1341-0788. (PMID: 33655056)
• 10 Efthimiou O, Mavridis D, Debray TP. et al. Combining randomized and non-randomized evidence in network meta-analysis. Stat Med 2017; 36: 1210-1226 DOI: 10.1002/sim.7223. (PMID: 28083901)
• 11 Kim MS, An MH, Kim WJ. et al. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. PLoS Med 2020; 17: e1003501 DOI: 10.1371/journal.pmed.1003501. (PMID: 33378357)
• 12 Shi J, Luo D, Weng H. et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 2020; 11: 641-654 DOI: 10.1002/jrsm.1429. (PMID: 32562361)
• 13 Papakonstantinou T, Nikolakopoulou A, Higgins JPT. et al. CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev 2020; 16: e1080 DOI: 10.1002/cl2.1080. (PMID: 37131978)
• 14 Sterne JAC, Savović J, Page MJ. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898 DOI: 10.1136/bmj.l4898. (PMID: 31462531)
• 15 Sterne JA, Hernán MA, Reeves BC. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919 DOI: 10.1136/bmj.i4919. (PMID: 27733354)
• 16 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
• 17 Balduzzi S, Rücker G, Nikolakopoulou A. et al. Netmeta: an R package for network meta-analysis using frequentist methods. J Stat Software 2023; 106: 1-40
• 18 Higgins JPT, Jackson D, Barrett JK. et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 2012; 3: 98-110 DOI: 10.1002/jrsm.1044. (PMID: 26062084)
• 19 Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol 2015; 15: 58 DOI: 10.1186/s12874-015-0060-8. (PMID: 26227148)
• 20 Fiori E, Crocetti D, Sapienza P. et al. Palliative surgery or metallic stent positioning for advanced gastric cancer: differences in QOL. Medicina (Kaunas) 2021; 57: 428 DOI: 10.3390/medicina57050428. (PMID: 33925171)
• 21 Mehta S, Hindmarsh A, Cheong E. et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006; 20: 239-242 DOI: 10.1007/s00464-005-0130-9. (PMID: 16362479)
• 22 Bian S-B, Shen W-S, Xi H-Q. et al. Palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer: a meta-analysis comparison of gastrojejunostomy with endoscopic stenting. Chin Med J 2016; 129: 1113-1121
• 23 Lorusso D, Giliberti A, Bianco M. et al. Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis. J Gastrointest Oncol 2019; 10: 283-291 DOI: 10.21037/jgo.2018.10.10. (PMID: 31032096)
• 24 Boghossian MB, Funari MP, De Moura DTH. et al. EUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis. Langenbecks Arch Surg 2021; 406: 1803-1817 DOI: 10.1007/s00423-021-02215-8. (PMID: 34121130)
• 25 Maetani I, Akatsuka S, Ikeda M. et al. Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol 2005; 40: 932-937
• 26 Maetani I, Tada T, Ukita T. et al. Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 2004; 36: 73-78
• 27 Kaminishi M, Yamaguchi H, Shimizu N. et al. Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma. Arch Surg 1997; 132: 184-187 DOI: 10.1001/archsurg.1997.01430260082018. (PMID: 9041924)
• 28 Ghandour B, Bejjani M, Irani SS. et al. Classification, outcomes, and management of misdeployed stents during EUS-guided gastroenterostomy. Gastrointest Endosc 2022; 95: 80-89
• 29 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Pancreatic Adenocarcinoma Version 2.2022 – 6 December 2022. Accessed April 24, 2024 at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455
• 30 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastric Cancer Version 1.2023 – 10 March 2023. Accessed April 24, 2024 at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1434
• 31 The National Institute for Health and Care Excellence of the United Kingdom. Pancreatic cancer in adults: diagnosis and management NICE guideline [NG85]. Accessed April 24, 2024 at: https://www.nice.org.uk/guidance/ng85
• 32 Ducreux M, Cuhna AS, Caramella C. et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 (Suppl. 5) v56-68 DOI: 10.1093/annonc/mdv295. (PMID: 26314780)
• 33 Committee of the Korean clinical practice guideline for pancreatic cancer and National Cancer Center, Korea. Korean clinical practice guideline for pancreatic cancer 2021: a summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches. Pancreatology 2021; 21: 1326-1341 DOI: 10.1016/j.pan.2021.05.004. (PMID: 34148794)
• 34 Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023; 26: 1-25
• 35 Okusaka T, Nakamura M, Yoshida M. et al. Clinical practice guidelines for pancreatic cancer 2019 from the Japan Pancreas Society: a synopsis. Pancreas 2020; 49: 326-335
• 36 Oesophago-gastric cancer: assessment and management in adults. NICE guideline [NG83]. Updated 4 July 2023. Accessed April 24, 2024 at: https://www.nice.org.uk/guidance/ng83